Sinotherapeutics Inc. (SHA:688247)

China · Delayed Price · Currency is CNY

10.28

-0.07 (-0.68%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical Manufacturing	511.62M	299.87M	247.56M	315.47M	319.16M
Pharmaceutical Manufacturing Growth	70.61%	21.13%	-21.53%	-1.16%	129.84%
Total	511.62M	299.87M	247.56M	315.47M	319.16M
Total Growth	70.61%	21.13%	-21.53%	-1.16%	129.84%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	303.13M	-	-	-	319.16M
China Growth	-	-	-	-	129.84%
Overseas	207.95M	-	-	-	-
Total	511.08M	-	-	-	319.16M
Total Growth	-	-	-	-	129.84%

Source: S&P Global Market Intelligence.